Life Sciences

Former Pfizer sales manager pleads guilty to misbranding

Pharma Compliance Alert, April 1, 2009

Mary Holloway, 47, of Branchburg, NJ, pleaded guilty to violating the Food, Drug, and Cosmetic Act while she worked as a regional manager for Pfizer, according to a Department of Justice release.

As a regional manager from approximately November 2001 through April 2005, Holloway was responsible for sales of the company’s COX-II inhibitor, Bextra. The FDA approved Bextra for use in treating osteoarthritis, adult rheumatoid arthritis, and primary dysmennorhea, but denied the company’s request to approve it for acute pain.

Read more about Holloway's guilty plea for misbranding.

Most Popular